1. Home
  2. LEGN vs BZ Comparison

LEGN vs BZ Comparison

Compare LEGN & BZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • BZ
  • Stock Information
  • Founded
  • LEGN 2014
  • BZ 2013
  • Country
  • LEGN United States
  • BZ China
  • Employees
  • LEGN N/A
  • BZ N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • BZ Computer Software: Programming Data Processing
  • Sector
  • LEGN Health Care
  • BZ Technology
  • Exchange
  • LEGN Nasdaq
  • BZ Nasdaq
  • Market Cap
  • LEGN 7.8B
  • BZ 7.2B
  • IPO Year
  • LEGN 2020
  • BZ 2021
  • Fundamental
  • Price
  • LEGN $34.68
  • BZ $13.91
  • Analyst Decision
  • LEGN Strong Buy
  • BZ Buy
  • Analyst Count
  • LEGN 13
  • BZ 7
  • Target Price
  • LEGN $81.54
  • BZ $20.00
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • BZ 5.3M
  • Earning Date
  • LEGN 11-12-2024
  • BZ 12-11-2024
  • Dividend Yield
  • LEGN N/A
  • BZ N/A
  • EPS Growth
  • LEGN N/A
  • BZ 148.30
  • EPS
  • LEGN N/A
  • BZ 0.46
  • Revenue
  • LEGN $520,183,000.00
  • BZ $1,013,942,831.00
  • Revenue This Year
  • LEGN $120.77
  • BZ $28.29
  • Revenue Next Year
  • LEGN $68.54
  • BZ $20.01
  • P/E Ratio
  • LEGN N/A
  • BZ $30.08
  • Revenue Growth
  • LEGN 122.96
  • BZ 30.40
  • 52 Week Low
  • LEGN $32.66
  • BZ $10.57
  • 52 Week High
  • LEGN $70.13
  • BZ $22.74
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 32.71
  • BZ 48.53
  • Support Level
  • LEGN $40.97
  • BZ $13.98
  • Resistance Level
  • LEGN $43.96
  • BZ $15.17
  • Average True Range (ATR)
  • LEGN 2.03
  • BZ 0.66
  • MACD
  • LEGN -0.72
  • BZ 0.10
  • Stochastic Oscillator
  • LEGN 16.97
  • BZ 46.05

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About BZ KANZHUN LIMITED American Depository Shares

Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on average number of monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.

Share on Social Networks: